|
|
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.
Stanislas Pol
,
Delphine Bonnet
,
Virginie Payssan-Sicart
,
Chloe Pomes
,
François Bailly
,
et al.
Journal articles
hal-03784807v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
Patrice Cacoub
,
Pierre Nahon
,
Richard Layese
,
Lorraine Blaise
,
Anne Claire Desbois
,
et al.
Journal articles
hal-02648446v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Stefan Zeuzem
,
Christophe Hezode
,
Jean-Pierre Bronowicki
,
Veronique Loustaud-Ratti
,
Francisco Gea
,
et al.
Journal articles
hal-01659111v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
Christophe Hezode
,
Pascal Lebray
,
Victor de Ledinghen
,
Fabien Zoulim
,
Vincent Di Martino
,
et al.
Journal articles
hal-01784615v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment
Arthur Berger
,
Federico Ravaioli
,
Oana Farcau
,
Davide Festi
,
Horia Stefanescu
,
et al.
Journal articles
hal-03258178v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte Costentin
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
,
et al.
Journal articles
hal-02648451v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study
Fabrice Carrat
,
Hélène Fontaine
,
Céline Dorival
,
Mélanie Simony
,
Alpha Diallo
,
et al.
Journal articles
hal-02050395v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort
Anne Laurain
,
Sophie Metivier
,
Georges Haour
,
Dominique Larrey
,
Céline Dorival
,
et al.
Journal articles
hal-02120879v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire
,
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
et al.
Journal articles
hal-02648452v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
SAT-490-No Impact of Direct-Acting Antivirals on Recurrent Hepatocellular Carcinoma Tumour Growth in the ANRS CO22 Hepather Cohort
Anais Vallet Pichard
,
Correas Jean Michel
,
Dorival Celine
,
Fabien Zoulim
,
Albert Tran
,
et al.
Journal articles
hal-03777536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
,
et al.
Journal articles
hal-02648450v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort
Ségolène Brichler
,
Pierre Nahon
,
Fabien Zoulim
,
Richard Layese
,
Valérie Bourcier
,
et al.
Journal articles
hal-03012001v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
Nathalie Ganne-Carrié
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
,
et al.
Journal articles
hal-01381662v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
Jessica Azzi
,
Céline Dorival
,
Carole Cagnot
,
Hélène Fontaine
,
Clovis Lusivika-Nzinga
,
et al.
Journal articles
hal-03651922v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study
Frédégonde About
,
Tiphaine Oudot-Mellakh
,
Jonathan Niay
,
Pascaline Rabiéga
,
Vincent Pedergnana
,
et al.
Journal articles
hal-01257993v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study
Laurent Lam
,
Hélène Fontaine
,
Marc Bourliere
,
Clovis Lusivika-Nzinga
,
Céline Dorival
,
et al.
Journal articles
hal-03224103v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Philippe Sultanik
,
Vincent Mallet
,
Sylvie Lagaye
,
Armanda Casrouge
,
Céline Dorival
,
et al.
Journal articles
istex
pasteur-01380846v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon
,
Valérie Bourcier
,
Richard Layese
,
Etienne Audureau
,
Carole Cagnot
,
et al.
Journal articles
hal-01447065v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|